Biogen Idec Inc (NASDAQ:BIIB)

360.67
Data as of Dec 19
 +6.97 / +1.97%
Today’s Change
270.62
Today|||52-Week Range
361.93
+29.01%
Year-to-Date
Agenus Jumps on Positive Data from Shingles Candidate - Analyst Blog
Dec 19 / Zacks.com
Strength Seen in GTX Inc (GTXI): Stock Rises 10.6% - Tale of the Tape
Dec 15 / Zacks.com
Integra Lifesciences Up on Launch of Bilayer Skin Product - Analyst Blog
Dec 19 / Zacks.com
Alder Biopharmaceuticals Slumps: ALDR Falls 5.5% in Session - Tale of the Tape
Dec 15 / Zacks.com
Seattle Genetics Initiates Phase Ib Study on Leukemia Drug - Analyst Blog
Dec 19 / Zacks.com
Teva's (TEVA) 2015 Guidance Hit By Generics - Analyst Blog
Dec 12 / Zacks.com
Cramer: bDownsideb to Biotech as ImmunoGen Stock Cut in Half
Dec 19 / TheStreet.com
Sangamo Biosciences (SGMO) Jumps: Stock Rises 7.2% - Tale of the Tape
Dec 12 / Zacks.com
Biogen Idec (BIIB) Showing Signs Of Perilous Reversal Today
Dec 19 / TheStreet.com
Alder Biopharmaceuticals Inc. (ALDR) in Focus: Stock Soars 31.9% - Tale of the Tape
Dec 12 / Zacks.com
3 Pharma Giants Growing Significantly Faster Than Pfizer, Inc.
Dec 19 / MotleyFool.com
Celladon Corporation (CLDN) Falls: Stock Goes Down 8.6% - Tale of the Tape
Dec 12 / Zacks.com
Second time lucky in biotech shares
Dec 19 / FT.com
3 Reasons Biogen Idec Inc. Could Soar in 2015
Dec 12 / MotleyFool.com
Bruker Unveils bioAFM System for High Resolution Imaging - Analyst Blog
Dec 18 / Zacks.com
PDL BioPharma's Q4 Revenues to Rise Y/Y on Higher Royalties - Analyst Blog
Dec 11 / Zacks.com
Watch For Today's Momo Momentum Stock: Biogen Idec (BIIB)
Dec 18 / TheStreet.com
Genomic Health's Liquid Biopsy Tests Positive in Twin Studies - Analyst Blog
Dec 11 / Zacks.com
Insider Trading Alert - UGI, BIIB And CAMP Traded By Insiders
Dec 17 / TheStreet.com
Ophthotech Corporation (OPHT) Jumps: Stock Gains 5% - Tale of the Tape
Dec 11 / Zacks.com
2015 Biotech Drug/Stock Outlook: Here's What You Need to Know
Dec 17 / TheStreet.com
Biogen Idec (BIIB) Stock: Moving Average Crossover Alert - Tale of the Tape
Dec 11 / Zacks.com
Alkermes Starts Phase I Study on Schizophrenia Candidate - Analyst Blog
Dec 16 / Zacks.com
Incyte (INCY) Gains on Positive Baricitinib Study Results - Analyst Blog
Dec 10 / Zacks.com
Is Illumina (ILMN) Worth Adding to Your Portfolio? - Analyst Blog
Dec 16 / Zacks.com
Biotech Stock Roundup: Cubist to be Acquired by Merck, Bluebird Shoots Up on ASH Data...
Dec 10 / Zacks.com
Acorda's Ampyra in Phase III for Post-Stroke Walking Deficit - Analyst Blog
Dec 16 / Zacks.com
JAZZ Pharmaceuticals Slips After Dosing Issue on JZP-386 - Analyst Blog
Dec 10 / Zacks.com
OPKO Up on Announcing Global Partnership with Pfizer - Analyst Blog
Dec 16 / Zacks.com
Myriad Genetics Unveils Positive Cancer Study Results - Analyst Blog
Dec 10 / Zacks.com
Genomic Health's Breast Cancer Test Yields Positive Results - Analyst Blog
Dec 16 / Zacks.com
AbbVie Reveals Phase II Data on Blood Cancer Drug at ASH (Revised) - Analyst Blog
Dec 10 / Zacks.com
Stock Market News for December 16, 2014 - Market News
Dec 16 / Zacks.com
Stock Market News for December 10, 2014 - Market News
Dec 10 / Zacks.com
OvaScience Slumps: OVAS Tanks 12.3% in Session - Tale of the Tape
Dec 16 / Zacks.com
Avalanche Biotechnologies (AAVL) Jumps: Stock Adds 6.1% in Session - Tale of the Tape
Dec 10 / Zacks.com
BioDelivery Sciences (BDSI) in Focus: Stock Tanks 11% - Tale of the Tape
Dec 16 / Zacks.com
3 Biotech Stocks to Buy in December
Dec 10 / MotleyFool.com
bluebird bio (BLUE) Crumbles: Stock Falls by 5.6% - Tale of the Tape
Dec 16 / Zacks.com
ISIS Jumps on Positive Results for Venous Thrombosis Drug - Analyst Blog
Dec 09 / Zacks.com
Trevena (TRVN) in Focus: Stock Rallies 7.5% - Tale of the Tape
Dec 16 / Zacks.com
Dynavax & AstraZeneca Alter Agreement for Asthma Product - Analyst Blog
Dec 09 / Zacks.com
Which Biotech Will Become the Next Gilead Sciences, Inc.?
Dec 16 / MotleyFool.com
Alnylam Reports Positive Initial Phase I Data on ALN-AT3 - Analyst Blog
Dec 09 / Zacks.com
Alexion's Soliris Receives Orphan Drug Status in Japan - Analyst Blog
Dec 15 / Zacks.com
Pharmacyclics Presents Imbruvica Data at the ASH Meeting - Analyst Blog
Dec 09 / Zacks.com
Jazz Pharmaceuticals Starts Defibrotide Rolling NDA Filing - Analyst Blog
Dec 15 / Zacks.com
Amgen Successfully Expands Xgeva Label in the U.S. - Analyst Blog
Dec 09 / Zacks.com
Puma Biotechnology Reveals Positive Interim PB272 Data - Analyst Blog
Dec 15 / Zacks.com
Celgene Up on Positive Revlimid Data Presented at ASH - Analyst Blog
Dec 09 / Zacks.com

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.